{"podcast":{"title":"The Curbsiders Internal Medicine Podcast","slug":"the-curbsiders-internal-medicine-podcast-743220","podcast_index_feed_id":743220,"rss_url":"https://audioboom.com/channels/5034728.rss","website_url":"https://audioboom.com/channels/5034728","image_url":"https://audioboom.com/i/37090939/s=1400x1400/el=1/rt=fill.jpg","author":"The Curbsiders Internal Medicine Podcast","episode_count":500,"summary":"The Curbsiders Internal Medicine Podcast brings you expert interviews, clinical pearls, and practice-changing knowledge — plus the occasional bad joke. Trusted by 100,000+ health professionals every month, we cover the full spectrum of internal medicine to keep you learning and laughing. No boring lectures here, just high-value content and a healthy dose of humor. Fantastic for Internal Medicine, Family Medicine, Primary Care, and Hospital Medicine. Support the show: patreon.com/curbsiders Download our Primary Care Starter Guide e-book patreon.com/c/curbsiders/shop","last_synced_at":"2026-07-06T14:20:46.768235+00:00","page_url":"https://stenobird.com/podcast/the-curbsiders-internal-medicine-podcast-743220"},"episode":{"title":"#517 DIGEST: Weight regain after weight loss medications, GLP1/GIP comparisons, valacyclovir for Alzheimer’s, and nudges to encourage deprescribing","slug":"517-digest-weight-regain-after-weight-loss-medications-glp1-gip-comparisons-valacyclovir-for-alzheimer-s-and-nudges-to-encourage-deprescribing","published_at":"2026-03-16T07:00:00+00:00","page_url":"https://stenobird.com/podcast/the-curbsiders-internal-medicine-podcast-743220/517-digest-weight-regain-after-weight-loss-medications-glp1-gip-comparisons-valacyclovir-for-alzheimer-s-and-nudges-to-encourage-deprescribing","show_page_url":"https://stenobird.com/podcast/the-curbsiders-internal-medicine-podcast-743220","url":"https://audioboom.com/posts/8874356","audio_url":"https://pdst.fm/e/arttrk.com/p/ABMA5/clrtpod.com/m/pscrb.fm/rss/p/dts.podtrac.com/redirect.mp3/audioboom.com/posts/8874356.mp3?modified=1780964725&sid=5034728&source=rss","summary":"Join us as we review and appraise recent practice-changing articles. In this episode, we cover the latest in GLP-1s and GIP agonists for CVD, Type 2 Diabetes, and Obesity, valacyclovir to treat Alzheimer’s, weight regain patterns after medication-induced weight loss, and a deep dive into the data behind deprescribing – and behavioral science to increase deprescribing behavior. Fill your brain hole with a delicious stack of hotcakes! Featuring Paul Williams ( @PaulNWilliamz ), Alex Chaitoff ( @alexchaitoff ), Nora Taranto ( @norataranto ), & Matt Watto (@doctorwatto) . Claim CME for this episode at curbsiders.vcuhealth.org ! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Credits Written and Hosted by: Nora Taranto MD, MSCE; Alexander Chaitoff MD, MPH; Paul Williams, MD, FACP,, & Matthew Watto MD, FACP Cover Art: Nora Taranto MD, MSCE Reviewer: Sai S Achi MD, MBA, FACP Technical Production: Pod Paste Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Show Segments Intro, disclaimer GLP-1 + GIPs vs GLP-1s for patients with T2DM and Obesity – SURPASS-CVOT Weight Regain after Weight loss VALAD – Valacyclovir in patients with early Alzheimer’s Nudges to increase Deprescribing Outro Sponsor: MedStudy Qbank Study less. Remember more. Pass confidently. Medstudy.com/Curbsiders CURB15 for 15% off Sponsor: FIGS We’ve teamed up with FIGS, and now Curbsiders listeners can get 15% off at Wearfigs.com with code FIGSRX . Sponsor: Quince Right now, go to Quince.com/curb for free shipping and 365-day returns. Sponsor: A Dangerous Diagnosis To get 20% off use DIAGNOSIS20 at www.penguinrandomhouse.com/books/808848/a-dangerous-diagnosis-by-shantanu-rai/paperback/","meta_description":"Join us as we review and appraise recent practice-changing articles. In this episode, we cover the latest in GLP-1s and GIP agonists for CVD, Type 2 Diabe…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3604,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-curbsiders-internal-medicine-podcast-743220/episodes/517-digest-weight-regain-after-weight-loss-medications-glp1-gip-comparisons-valacyclovir-for-alzheimer-s-and-nudges-to-encourage-deprescribing/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-curbsiders-internal-medicine-podcast-743220/517-digest-weight-regain-after-weight-loss-medications-glp1-gip-comparisons-valacyclovir-for-alzheimer-s-and-nudges-to-encourage-deprescribing.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}